[1]
A. Abd-rabou, H. Ahmed, and E. Eskander, “CLEMASTINE, THE H1 HISTAMINE RECEPTOR ANTAGONIST, ALTERS THE HUMAN SEX AND THYROID HORMONAL PROFILES”, Asian J Pharm Clin Res, vol. 10, no. 8, pp. 327-330, Aug. 2017.